[1] 张倩,李建涛,宋春霞.阿尔茨海默病治疗药物研究进展[J].中国老年学杂志,2015,35(8): 2282-2285.
[2] 彭丹涛,于普林.阿尔茨海默病患者就诊状况及多奈哌齐治疗效果的调查[J].中华老年医学杂志,2010,29(8): 691-693.
[3] 杨静,杨传英,宋超.盐酸多奈哌齐与石杉碱甲治疗阿尔茨海默病的疗效[J].中国老年学杂志,2012,32(21): 4631-4633.
[4] 张营丽,唐伟,王威.阿尔茨海默病诊断与治疗策略[J].中国老年学杂志,2015,35(3): 862-864.
[5] Takeda S,Sato N,Ikimura K,et al.Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model [J].Neurobiol Aging,2013,34(8): 2064-2070.
[6] 王爱霞,王瑞婷,狄婷婷.小胶质细胞在阿尔茨海默病中作用的研究进展[J].中国老年学杂志,2015,35(16): 4715-4718.
[7] Yang WN,Han H,Hu XD,et al.The effects of perindopril on cognitive impairment induced by d-galactose and aluminum trichloride via inhibition of acetylcholinesterase activity and oxidative stress[J].Pharmacol Biochem Behav,2013,114-115 (12): 31-36.
[8] 王延江,卜先乐.阿尔茨海默病的防治研究进展[J].第三军医大学学报,2014,36(21):2153-2157.
[9] Barrantes FJ,Borroni V,Vallés S,et al.Neuronal nicotinic acetylcholine receptor-cholesterol crosstalk in Alzheimer's disease[J].FEBS Lett,2010,584(9): 1856-1863.
[10] 黄海华,李明秋,江皋轩,等.多奈哌齐治疗阿尔茨海默病的远期疗效观察[J].中华老年医学杂志,2012,31(2):98-101.
[11] 杨南竹,贠相华,周玉颖.多奈哌齐治疗阿尔茨海默病的系统评价[J].中华老年心脑血管病杂志,2015,17(1): 61-66.
[12] 毕炳添,徐江平.C反应蛋白对β淀粉样蛋白生成的调节参与Alzheimer's disease病发病的研究[J].中国药理学与毒理学杂志,2012,26(3): 419-420.
[13] Ernst A,Morgenthaler NG,Buerger K,et al.Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation [J].J Neuroimmunol,2007,189(1-2): 169-174. |
2018, Vol. 35 
